Mark G. Lebwohl

机构：Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai · ORCID：0000-0002-4705-5303

发表论文 102 篇 · 总被引 1876 次 · h-index 22

代表论文

• Deucravacitinib in plaque psoriasis: Four‐year safety and efficacy results from the Phase 3 POETYK PSO ‐1, PSO ‐2 and long‐term extension trials (2025 · Journal of the European Academy of Dermatology and Venereology · 被引 41)
• Defining On-Treatment Remission in Plaque Psoriasis (2025 · JAMA Dermatology · 被引 12)
• Systemic Janus kinase inhibitors in the management of granuloma annulare (2025 · Archives of Dermatological Research · 被引 8)
• Management of Chronic Generalized Pustular Psoriasis: A Review and Expert Opinion (2025 · Journal of Psoriasis and Psoriatic Arthritis · 被引 8)
• Deucravacitinib: Adverse Events of Interest Across Phase 3 Plaque Psoriasis Trials (2025 · Dermatology and Therapy · 被引 8)
• POS1072 Icotrokinra, a Targeted Oral Peptide That Selectively Blocks the Interleukin-23-Receptor, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Results Through Week 24 of the Phase 3, Randomized, Double-Blind, Placebo-Controlled ICONIC-LEAD Trial (2025 · Annals of the Rheumatic Diseases · 被引 6)